According to a new report, published by KBV research, The Global Infant Incubator Market size is expected to reach $944.9 million by 2030, rising at a market growth of 6.8% CAGR during the forecast period. In the year 2022, the market attained a volume of 321.9 thousand units, experiencing a growth of 7.0% (2019-2022).
The Transport Incubator segment is experiencing a CAGR of 7.3% during (2023 - 2030). Transport incubators are designed to absorb shocks and vibrations during movement. This is particularly important during ambulance or helicopter transport, where the device must withstand different terrains' rigors. The stability of the incubator ensures the infant's safety and minimizes potential disruptions to medical equipment. Transport incubators are invaluable tools in neonatal care, allowing for the safe transportation of critically ill or premature infants to facilities with specialized medical expertise. Their features are tailored to meet the unique challenges of transporting newborns while ensuring their well-being and stability throughout the journey.
The Neonatal hypothermia & low birth weight segment is leading the Global Infant Incubator Market, by Application in 2022; thereby, achieving a market value of $586.2 Million by 2030. This is a serious concern because infants, especially premature or low-birth-weight babies, have limited ability to regulate their body temperature. Preserving a stable body temperature is crucial for the well-being and survival of newborns. Hypothermic infants may require more oxygen to maintain normal bodily functions. Therapeutic hypothermia is a controlled lowering of the body temperature for medical purposes. In certain cases, such as when a newborn experiences birth asphyxia, therapeutic hypothermia may be intentionally induced to reduce the risk of neurological damage. This is a carefully managed medical intervention under specific conditions and is different from accidental neonatal hypothermia.
The Maternity Hospitals segment is registering a CAGR of 7.4% during (2023 - 2030). Modern maternity hospitals focus on providing state-of-the-art facilities for prenatal, intrapartum, and postpartum care. This includes well-equipped delivery rooms, operating theaters for cesarean sections, and neonatal care units. Maternity hospitals increasingly offer birthing suites designed for a comfortable and home-like environment, allowing mothers a more personalized and less clinical birthing experience. Maternity hospitals incorporate advanced medical equipment for fetal monitoring, diagnostic imaging, and other medical interventions to ensure the best possible outcomes for both mother and baby.
The North America region dominated the Global Infant Incubator Market, by Region in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $402.8 Million by 2030. The Europe region is anticipating a CAGR of 6.6% during (2023 - 2030). Additionally, The Asia Pacific region would exhibit a CAGR of 7.7% during (2023 - 2030).
Full Report: https://www.kbvresearch.com/infant-incubator-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of GE HealthCare Technologies, Inc., Natus Medical Incorporated (Archimed SAS), Atom Medical Corporation, Phoenix Medical Systems Pvt. Ltd., Dragerwerk AG & Co. KGaA, Inspiration Healthcare Group PLC, Medicor Elektronika Zrt., Fanem Ltda., Koninklijke Philips N.V., Médipréma Group
By Product (Volume, Thousand Units, USD Million, 2019 to 2030)
By Application (Volume, Thousand Units, USD Million, 2019 to 2030)
By End User (Volume, Thousand Units, USD Million, 2019 to 2030)
By Geography (Volume, Thousand Units, USD Million, 2019 to 2030)
Companies Profiled
Unique Offerings 
